The Newsroom sat down with Marcus Garcia, senior director of payer and strategy relations at Rocky Mountain Cancer Centers to discuss the benefits of doctors referring patients to infusion centers.

As promising biosimilar therapies to treat inflammatory conditions become available next year, Cigna Pharmacy Management, which manages pharmacy benefits for some Cigna Healthcare clients, is announcing that it will add select biosimilars as preferred products on its commercial formularies at the same position as Humira.

Cigna Healthcare has found that the average annual price of therapy for specialty drugs is $38,000 per patient, which is 75 times higher than non-specialty prescription drugs.

To better understand OCD, we sat down with Dr. Jamie Feusner, chief medical officer at NOCD, an organization that provides evidence-based treatments for people with OCD, to talk about the condition, how it shows up in different people, and the causes, treatment, and side effects of living with it.

High medical costs are inevitable. But they’re also predictable and manageable with the right data. Employers must understand the needs of their employees, in order to anticipate, address and manage high medical costs.